Study guide
23.8 Medicaments, Obturation Materials and Techniques
Overseas Registration Examination ORE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy
1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits
2 Chapter 2: Anatomy of the Head and Neck
2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection
3 Chapter 3: Dental Anatomy, Morphology and Occlusion
3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships
4 Chapter 4: Genetics, Embryology and Odontogenesis
4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies
5 Chapter 5: Oral Biology and Salivary Physiology
5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics
6 Chapter 6: Physiology of the Major Body Systems
6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System
7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing
7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk
8 Chapter 8: Oral Microbiology and Biofilm Ecology
8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control
9 Chapter 9: Immunology Relevant to Oral Disease
9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations
10 Chapter 10: General Pathology and Neoplasia
10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma
11 Chapter 11: Statistics and Research Methods
11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance
12 Chapter 12: Human Disease: Cardiovascular and Respiratory
12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies
13 Chapter 13: Human Disease: Endocrine, Haematological and Renal
13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis
14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological
14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis
15 Chapter 15: Oral Aspects of Human Disease
15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis
16 Chapter 16: Infection Prevention and Control
16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses
17 Chapter 17: Dental Materials
17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers
18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care
18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health
19 Chapter 19: Patient Assessment and Diagnosis
19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis
20 Chapter 20: Treatment Planning and Risk-Based Care
20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning
21 Chapter 21: Cariology and Caries Risk Assessment
21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment
22 Chapter 22: Operative Dentistry and Minimal Intervention
22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry
23 Chapter 23: Endodontics
23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture
24 Chapter 24: Periodontology
24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care
25 Chapter 25: Fixed Prosthodontics
25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements
26 Chapter 26: Removable Prosthodontics
26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration
27 Chapter 27: Paediatric Dentistry
27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits
28 Chapter 28: Dental Traumatology
28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications
29 Chapter 29: Orthodontics
29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention
30 Chapter 30: Oral Surgery
30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread
31 Chapter 31: Oral Medicine
31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy
32 Chapter 32: Oral Pathology
32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms
33 Chapter 33: Therapeutics and Prescribing
33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics
34 Chapter 34: Medical Emergencies in Dental Practice
34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation
35 Chapter 35: Dental Radiology and Radiation Protection
35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017
36 Chapter 36: Special Care Dentistry and Conscious Sedation
36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral
37 Chapter 37: Dental Public Health
37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning
38 Chapter 38: Communication and Interpersonal Skills
38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team
39 Chapter 39: Consent and Capacity
39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure
40 Chapter 40: Clinical Professionalism and the GDC
40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle
41 Chapter 41: Health and Safety Law in Dental Practice
41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps
42 Chapter 42: Self-Management and Professional Development
42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management
23.8 Medicaments, Obturation Materials and Techniques
Key Takeaways Explain This Topic AI
Non-setting calcium hydroxide reaches a pH of about 12.5 and neutralises lipopolysaccharide, but requires a minimum of 7 to 14 days in the canal.
Clinical gutta-percha cones are only about 20% gutta-percha, with roughly 65% zinc oxide filler plus waxes, resins and radiopacifiers.
Beta-phase gutta-percha is the stable form at room temperature; heating converts it to the alpha phase for warm vertical compaction.
Bioceramic sealers set by hydration to form hydroxyapatite and are used with single-cone techniques, whereas epoxy resin sealers remain the benchmark for lateral compaction.
In cold lateral compaction a finger spreader is inserted alongside the master cone to within 1.0 to 2.0 mm of working length, whereas warm vertical compaction uses a downpack and backfill.
Last updated: September 2026
Intracanal Medicaments
When endodontic treatment cannot be completed in a single visit, an intracanal medicament is placed to maintain disinfection and suppress microbial regrowth.
Calcium Hydroxide ( Ca(OH) 2 \text{Ca(OH)}_2 Ca(OH) 2 )
Properties: White, odourless powder mixed into a non-setting aqueous paste (e.g., Hypocal, Ultracal).
Mechanism: Sustained dissociation into calcium ( Ca 2 + \text{Ca}^{2+} Ca 2 + ) and hydroxyl ( OH − \text{OH}^- OH − ) ions generates an intensely alkaline environment (pH ~12.5) . Hydroxyl ions:
- Damage bacterial cytoplasmic membranes through lipid peroxidation;
- Denature structural proteins and metabolic enzymes;
Inactivate and hydrolyze bacterial lipopolysaccharide (LPS / endotoxin) , neutralizing its periapical osteoclast-stimulating toxicity;
Aid in the dissolution of residual necrotic tissue remnants.
Duration: Requires a minimum of 7 to 14 days inside the canal to penetrate the full thickness of dentinal tubules and overcome dentine's natural buffering capacity.
Contraindication: Never seal calcium hydroxide into an actively exuding canal or acute apical abscess without first achieving dry canal drainage.
Ledermix & Odontopaste
Formulation:
Ledermix: Corticosteroid ( triamcinolone acetonide 1% ) + Tetracycline antibiotic ( demeclocycline calcium 3.21% ). Demeclocycline can cause severe gray-brown tooth discolouration if exposed to sunlight; must be kept below the amelocemental junction (ACJ).
Odontopaste: Corticosteroid ( triamcinolone acetonide 1% ) + Lincosamide antibiotic ( clindamycin hydrochloride 5% ) + calcium hydroxide; does not cause cosmetic crown staining.
Indication: Specifically indicated as an emergency dressing in cases of acute symptomatic irreversible pulpitis when time constraints prevent complete chemomechanical instrumentation. The corticosteroid rapidly diffuses across dentinal tubules and apical tissues, downregulating phospholipase A2 and cyclooxygenase enzymes, curbing prostaglandin synthesis and providing dramatic pain relief.
Criteria for Obturation
Obturation seals the shaped and disinfected root canal space, preventing coronal microleakage, entombing residual microorganisms, and eliminating dead spaces that could harbour periapical exudate.
Obturation must only proceed when the following clinical criteria are met:
Asymptomatic Tooth: The patient must be free of spontaneous pain, with no significant tenderness to mechanical percussion or apical palpation.
Dry Canal: The canal must be completely dry upon paper point insertion. Persistent weeping of clear inflammatory serous exudate, purulent discharge, or persistent apical haemorrhage indicates active periapical inflammation, precluding obturation.
Absence of Swelling or Active Sinus Tract: Soft tissues must be completely non-swollen, and any pre-existing sinus tract should show evidence of healing or closure.
Intact Coronal Seal & Isolation: The treatment field must remain strictly isolated with rubber dam, with no saliva contamination.
Core Obturation Materials: Gutta-Percha
Gutta-percha (GP) is the standard core filling material. Chemically, it is the trans-isomer of polyisoprene ( 1 , 4 -polyisoprene 1,4\text{-polyisoprene} 1 , 4 -polyisoprene ), contrasting with natural rubber (which is the cis-isomer).
Crystalline Phases of Gutta-Percha
Gutta-percha exhibits two distinct crystalline forms depending on temperature:
Beta (β) Phase:
The unheated, solid crystalline state present at room temperature (below 42°C).
In this phase, GP is firm, compactable, and possesses dimensional stability.
Master cones used in cold lateral compaction are manufactured in the β-phase.
Alpha (α) Phase:
When heated between 42°C and 49°C, GP undergoes an endothermic phase transition into the α-phase.
In this phase, GP becomes soft, pliable, amorphous, tacky, and flows under light hydraulic pressure.
Utilized in thermoplasticized warm vertical compaction and injectable backfill systems.
Physical Property: Upon cooling, α-phase GP shrinks by 1% to 2% as it recrystallizes into the β-phase; warm compaction techniques require continuous vertical pressure during cooling to compensate for this thermal contraction.
Composition of Clinical Gutta-Percha Cones
Standard commercial gutta-percha cones contain:
Zinc Oxide (Filler): ~60% – 65% (provides stiffness and antibacterial activity).
Gutta-Percha (Organic Matrix): ~19% – 22% (provides plasticity and core substance).
Heavy Metal Sulfates (Barium sulfate, Bismuth subcarbonate): ~10% – 15% (radiopacifiers).
Waxes and Resins (Plasticizers): ~1% – 4% (impart pliability and flow properties).
Endodontic Sealers
Gutta-percha does not adhere to dentine walls. An endodontic sealer is mandatory to fill the microscopic interface, seal dentinal tubule apertures, fill lateral canals, and act as a fluid-tight adhesive barrier.
Sealer Class Key Examples Advantages Disadvantages / Clinical Milestones
Epoxy Resin-Based AH Plus, TopSeal Gold-standard benchmark; superior dimensional stability, minimal shrinkage on setting, low solubility, excellent adhesion to dentine, deep tubule penetration Initial mild cytotoxicity before setting; insoluble in water; non-bioactive; eugenol residues can inhibit setting
Bioceramic / Calcium Silicate-Based TotalFill BC Sealer, BioRoot RCS, Endosequence BC Highly biocompatible; non-cytotoxic; hydrophilic (sets in presence of dentinal moisture); forms hydroxyapatite chemical bond (mineral infiltration zone); alkaline pH (~12); zero shrinkage (slight expansion ~0.2%) Very difficult to retreat if set solid without a master GP cone; expensive; fast-setting in humid canals
Zinc Oxide Eugenol (ZOE) Tubli-Seal, Roth's, Pulp Canal Sealer Long clinical track record; resorbable if extruded into periapical tissues; antimicrobial Significant shrinkage upon setting; highly soluble over time; releases cytotoxic free eugenol; eugenol inhibits resin bonding
Calcium Hydroxide-Based Sealapex, Apexit Releases OH − \text{OH}^- OH − ions; initial antibacterial action; osteogenic potential High solubility in tissue fluids; weak cohesive strength; decomposes over long-term follow-up
Note
Bioceramic Sealer Setting Reaction: Tricalcium silicate ( C 3 S \text{C}_3\text{S} C 3 S ) reacts with dentinal moisture to produce a calcium silicate hydrate ( C-S-H \text{C-S-H} C-S-H ) gel and calcium hydroxide ( Ca(OH) 2 \text{Ca(OH)}_2 Ca(OH) 2 ). The released Ca(OH) 2 \text{Ca(OH)}_2 Ca(OH) 2 precipitates with tissue phosphate ions to form hydroxyapatite crystals along the dentine-sealer interface, creating a chemical "mineral infiltration zone" with micromechanical tag formation.
Obturation Techniques
Cold Lateral Compaction:
Technique: A master gutta-percha cone matching the Master Apical File (MAF) size and taper is fitted to full working length, confirming tactile resistance to displacement ( tug-back ). Sealer is introduced into the canal. The master cone is inserted. A hand or finger spreader is inserted alongside the master cone to within 1.0–2.0 mm of WL, compressing the cone laterally against the wall. The spreader is rotated and removed, and accessory gutta-percha cones are sequentially placed into the void created until the spreader cannot penetrate beyond the coronal third.
Evaluation: Simple, predictable length control. However, it produces a non-homogeneous mass of cones held by sealer lakes, does not replicate complex canal irregularities or C-shaped fins, and hand spreaders generate high wedge-like lateral stresses predisposing to vertical root fracture (VRF) . Finger spreaders reduce this risk.
Warm Vertical Compaction (Continuous Wave of Condensation, e.g., System B):
Technique: A non-standardized tapered master cone is trimmed 0.5 mm short of WL to achieve apical tug-back. Coated with sealer. An electric heat plugger activated to 200°C is advanced rapidly through the master cone to a binding point 3.0 to 5.0 mm short of WL, searing off coronal GP ( downpack ). Firm vertical pressure is maintained on the apical plug with a hand plugger as it cools to compensate for thermal shrinkage. The remaining canal space is then backfilled with thermoplasticized α-phase GP from an extruder gun ( backfill ) in increments.
Evaluation: Produces a dense, homogeneous 3D obturation replicating lateral canals, isthmuses, and apical deltas. Requires careful temperature control to avoid PDL overheating (>10°C rise damages bone).
Carrier-Based Obturation (Thermafil / GuttaCore):
Utilizes a plastic or cross-linked gutta-percha core carrier coated with α-phase gutta-percha, heated in a dedicated oven and inserted in a single movement to WL. Excellent flow into lateral anatomy, but prone to stripping of GP at the apex during placement, extrusion beyond foramen, and difficulty during post-space preparation or retreatment.